P. Nanni; V. Gatta; L. Menotti; C. De Giovanni; M. Ianzano; A. Palladini; V. Grosso; M. Dall’Ora; S. Croci; G. Nicoletti; L. Landuzzi; M. Iezzi; G. Campadelli-Fiume; P.-L. Lollini., Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus., «PLOS PATHOGENS», 2013, 9, Article number: e1003155, pp. 1 - 10 [articolo]Open Access
Reisoli E.; Gambini E.; Appolloni I.; Gatta V.; Barilari M.; Menotti L.; Malatesta P., Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice., «CANCER GENE THERAPY», 2012, 19, pp. 788 - 795 [articolo]
Gambini E.; Reisoli E.; Appolloni I.; Gatta V.; Campadelli-Fiume G.;
Menotti L.; Malatesta P., Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma, «MOLECULAR THERAPY», 2012, 20, pp. 994 - 1001 [articolo]
G. Campadelli-Fiume; C. De Giovanni; V. Gatta; P. Nanni; P.L. Lollini; L. Menotti, Rethinking herpes simplex virus: the way to oncolytic agents., «REVIEWS IN MEDICAL VIROLOGY», 2011, 21, pp. 213 - 226 [articolo]
Gianni T.; Gatta V.; Campadelli-Fiume G., {alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2., «PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA», 2010, 107, pp. 22260 - 22265 [articolo]
Monti B.; Gatta V.; Piretti F.; Raffaelli S.; Virgili M.; Contestabile A., Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha synuclein, «NEUROTOXICITY RESEARCH», 2010, 17, pp. 130 - 141 [articolo]
Menotti L.; Nicoletti G.; Gatta V.; Croci S.; Landuzzi L.; De Giovanni C.; Nanni P.; Lollini P.L.; Campadelli-Fiume G., Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells., «PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA», 2009, 106, pp. 9039 - 9044 [articolo]
